Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22

Related Articles by Review for PubMed (Select 10929035)

1.

Expression of urokinase plasminogen activator and the urokinase plasminogen activator receptor in myeloma cells.

Hjertner O, Qvigstad G, Hjorth-Hansen H, Seidel C, Woodliff J, Epstein J, Waage A, Sundan A, Börset M.

Br J Haematol. 2000 Jun;109(4):815-22.

PMID:
10929035
2.

Regulation and role of urokinase plasminogen activator in vascular remodelling.

Tkachuk V, Stepanova V, Little PJ, Bobik A.

Clin Exp Pharmacol Physiol. 1996 Sep;23(9):759-65. Review.

PMID:
8911711
3.

Inhibition of the tumor-associated urokinase-type plasminogen activation system: effects of high-level synthesis of soluble urokinase receptor in ovarian and breast cancer cells in vitro and in vivo.

Magdolen V, Krüger A, Sato S, Nagel J, Sperl S, Reuning U, Rettenberger P, Magdolen U, Schmitt M.

Recent Results Cancer Res. 2003;162:43-63. Review.

PMID:
12790320
4.

Urokinase-type plasminogen activator (uPA) and its receptor (uPAR): development of antagonists of uPA/uPAR interaction and their effects in vitro and in vivo.

Reuning U, Sperl S, Kopitz C, Kessler H, Krüger A, Schmitt M, Magdolen V.

Curr Pharm Des. 2003;9(19):1529-43. Review.

PMID:
12871066
5.
6.
7.

The role of urokinase-type plasminogen activator in aggressive tumor cell behavior.

Testa JE, Quigley JP.

Cancer Metastasis Rev. 1990 Dec;9(4):353-67. Review.

PMID:
2129023
8.

Proteolysis and invasiveness of brain tumors: role of urokinase-type plasminogen activator receptor.

Mohanam S, Sawaya RE, Yamamoto M, Bruner JM, Nicholson GL, Rao JS.

J Neurooncol. 1994;22(2):153-60. Review.

PMID:
7745467
9.

Plasminogen activation in human leukemia and in normal hematopoietic cells.

Mustjoki S, Alitalo R, Stephens RW, Vaheri A.

APMIS. 1999 Jan;107(1):144-9. Review.

PMID:
10190291
10.

The receptor for urokinase-plasminogen activator.

Blasi F, Stoppelli MP, Cubellis MV.

J Cell Biochem. 1986;32(3):179-86. Review.

PMID:
3023408
11.

Flow cytofluorometry in tumour cell receptor analysis. Survey of the literature and recent developments concerning the urokinase-type plasminogen activator (uPA).

Chucholowski N, Schmitt M, Goretzki L, Schüren E, Moniwa N, Weidle U, Kramer M, Wagner B, Jänicke F, Graeff H.

Biochem Soc Trans. 1992 Feb;20(1):208-16. Review. No abstract available.

PMID:
1321752
12.

CD87 (urokinase-type plasminogen activator receptor), function and pathology in hematological disorders: a review.

Béné MC, Castoldi G, Knapp W, Rigolin GM, Escribano L, Lemez P, Ludwig WD, Matutes E, Orfao A, Lanza F, van't Veer M; EGIL, European Group on Immunological Classification of Leukemias.

Leukemia. 2004 Mar;18(3):394-400. Review.

PMID:
14671631
13.

Clinical applications of the urokinase receptor (uPAR) for cancer patients.

Boonstra MC, Verspaget HW, Ganesh S, Kubben FJ, Vahrmeijer AL, van de Velde CJ, Kuppen PJ, Quax PH, Sier CF.

Curr Pharm Des. 2011;17(19):1890-910. Review.

PMID:
21711239
14.

[Involvement of urokinase and its receptor in the remodeling of normal and pathological tissue].

Tkachuk VA, Stepanova VV, Volynskaia EA.

Vestn Ross Akad Med Nauk. 1998;(8):36-41. Review. Russian.

PMID:
9771129
15.

The urokinase-receptor in infectious diseases.

Montuori N, Selleri C, Ragno P.

Infez Med. 2012;20 Suppl 2:13-8. Review.

16.

A new approach to phenotyping disseminated tumor cells: methodological advances and clinical implications.

Noack F, Schmitt M, Bauer J, Helmecke D, Krüger W, Thorban S, Sandherr M, Kuhn W, Graeff H, Harbeck N.

Int J Biol Markers. 2000 Jan-Mar;15(1):100-4. Review.

PMID:
10763150
17.

Invasive capacity of heterotopic endometrium.

Kobayashi H.

Gynecol Obstet Invest. 2000;50 Suppl 1:26-32. Review.

PMID:
11093058
18.

The plasminogen activation system in melanoma cell lines and in melanocytic lesions.

de Vries TJ, van Muijen GN, Ruiter DJ.

Melanoma Res. 1996 Apr;6(2):79-88. Review.

PMID:
8791264
19.

Antisense oligonucleotides against the urokinase receptor: a therapeutic strategy for the control of cell invasion in rheumatoid arthritis and cancer.

Del Rosso M, Fibbi G, Pucci M, Cerinic MM.

Clin Exp Rheumatol. 1998 Jul-Aug;16(4):389-93. Review. No abstract available.

PMID:
9706415
20.

[The structure and function of urokinase receptor and its expression in neoplastic tissues].

Tang H, Zhu Y, Song H.

Zhonghua Yi Xue Za Zhi. 1995 May;75(5):315-7. Review. Chinese. No abstract available.

PMID:
7656166
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk